Umbralisib: Walking the Tightrope of PI3K Inhibition in Indolent NHL

J Clin Oncol. 2021 May 20;39(15):1671-1673. doi: 10.1200/JCO.21.00284. Epub 2021 Apr 16.

Authors

Stephen D Smith^{1

2

3}, Ajay K Gopal^{1

2

3}

Affiliations

¹ Division of Medical Oncology, Department of Internal Medicine, University of Washington, Seattle, WA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
³ Seattle Cancer Care Alliance, Seattle, WA.

PMID: 33861621
DOI: 10.1200/JCO.21.00284

No abstract available

Publication types

Comment

MeSH terms

Heterocyclic Compounds, 4 or More Rings
Humans
Lymphoma, Non-Hodgkin*
Phosphatidylinositol 3-Kinases*

Substances

Heterocyclic Compounds, 4 or More Rings
umbralisib